Holen Sie sich die Stockscreener-App
70.19
8.39%
-6.43
Vorhandelsmarkt:
70.01
-0.18
-0.26%
Schlusskurs vom Vortag:
$76.62
Offen:
$74.73
24-Stunden-Volumen:
3.11M
Relative Volume:
2.93
Marktkapitalisierung:
$12.14B
Einnahmen:
$8.26B
Nettoeinkommen (Verlust:
$66.00M
KGV:
190.63
EPS:
0.3682
Netto-Cashflow:
$1.17B
1W Leistung:
-7.05%
1M Leistung:
-12.44%
6M Leistung:
+4.36%
1J Leistung:
+0.00%
1-Tages-Spanne:
$70.03
$74.73
1-Wochen-Bereich:
$70.03
$77.75
52-Wochen-Spanne:
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
70.19 | 12.14B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
ISRG
Intuitive Surgical Inc
|
494.61 | 177.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
221.59 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
89.61 | 44.32B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.35 | 31.33B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
31.35 | 16.08B | 17.28B | 108.00M | 391.00M | 0.20 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum Stock: Is SOLV Outperforming the Healthcare Sector? - Nasdaq
Solventum Stock: Is SOLV Outperforming The Healthcare Sector? - Barchart.com
Solventum Partners With SprintRay for Same-Day Dental Restorations - MSN
Solventum partners with SprintRay for 3D dental printing - MSN
Is Solventum (NYSE:SOLV) Using Too Much Debt? - simplywall.st
Solventum CEO made $14.8M in first year of 3M spinoff - Star Tribune
Solventum cuts 800 positions - MedTech Dive
Solventum and SprintRay enter dental 3D printing partnership - VoxelMatters
Solventum inks 3D dental printing partnership with SprintRay - Mass Device
Solventum Partners With SprintRay for Quick 3D-Printed Dental Restorations - MarketScreener
Solventum partners with SprintRay for dental 3D printing By Investing.com - Investing.com Australia
Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations - Quantisnow
Solventum partners with SprintRay for dental 3D printing - Investing.com India
Solventum paid CEO Bryan Hanson $40M in spinoff’s first year - Medical Design & Outsourcing
3M’s Healthcare Spinoff Stock Fell. This Is What It’s Worth. - MSN
New Solventum layoff details emerge, including 110 Minnesota job cuts - MSN
SEC Form DEF 14A filed by Solventum Corporation - Quantisnow
Solventum reaffirms 2025 guidance, and announces long-range plan through 2028 - MSN
3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy - Yahoo Finance
Stifel maintains Buy rating and $88 target on Solventum stock By Investing.com - Investing.com Canada
Mizuho Securities Raises Price Target on Solventum to $85 From $82, Keeps Neutral Rating - MarketScreener
Stifel maintains Buy rating and $88 target on Solventum stock - Investing.com
Analysts Have Conflicting Sentiments on These NA Companies: Solventum Corporation (SOLV) and ZEEKR Intelligent Technology Holding Limited Sponsored ADR (ZK) - The Globe and Mail
Mizuho raises Solventum stock target to $85, maintains neutral By Investing.com - Investing.com South Africa
Mizuho raises Solventum stock target to $85, maintains neutral - Investing.com
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
Solventum offers new details on layoffs and plans for growth - Mass Device
Solventum outlines growth strategy at 2025 Investor Day By Investing.com - Investing.com South Africa
Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day - Kilgore News Herald
Should You Invest in Solventum Corporation (SOLV)? - Insider Monkey
Solventum (SOLV): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy - MSN
Thermo Fisher to Acquire Solventum’s Purification and Filtration Business - The Healthcare Technology Report.
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum launches electronic sterilisation testing system - MSN
Jones Financial Companies Lllp Grows Stock Holdings in Solventum Co. (NYSE:SOLV) - Defense World
Thermo Fisher Strikes Deal for Solventum’s Filtration Unit - MSN
Agree To Buy Solventum At $50, Earn 2.9% Annualized Using Options - Nasdaq
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.94%
1.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):